Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IN8BIO, INC. Director's Dealing 2024

Dec 23, 2024

35200_dirs_2024-12-23_0e8bd726-ab2a-4b7f-887f-a25c53daa04c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2024-12-19

Reporting Person: Greenwood Luba (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-12-19 Stock Option (right to buy) $0.24 A 39449 Acquired 2034-12-19 Common Stock (39449) Direct

Footnotes

F1: The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date.